Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Clin Transplant. 2020 Oct 28;34(12):e14109. doi: 10.1111/ctr.14109

Fig. 1:

Fig. 1:

Use of advanced therapies while on the waitlist in patients with restrictive, infiltrative, and hypertrophic cardiomyopathies listed for heart transplant pre- and post-policy change. ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LVAD, left ventricular assist device